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Abstract
In Mozambique, the Expanded Program on Immunization (EPI) was 
implemented in 1979 with the objective of reducing child mortality and 
morbidity through the provision of immunization services. This study aims 
to describe the characteristics of the EPI and review the available information 
related to immunization service in Mozambique, its accomplishments and 
perspectives. A narrative review of the literature was carried out and the 
electronic databases accessed were VHL, Google Scholar, and PubMed 
between 1979 and 2019, using descriptors related to the theme. A total of 28 
articles and other relevant sources have been consulted for the review. The 
national immunization coverage in Mozambique between 1997 (47%) and 
2015 (66%) improved 19 percentual points; also immunization coverage of 
children under 12 months has increased from 44.3% (1997) to 57% (2015). 
The 2015 survey showed that out of the 11 provinces, only the southern 
and Cabo Delgado province could reach the 80% recommended goal at the 
provincial level. Zambézia, Nampula, and Tete provinces have been reporting 
low coverage over the years and Cabo Delgado presents coverage oscillation. 
The BCG, DPT3, Polio3, and measles have reached 80% of coverage goal 
from 1997 to 2015. Our analysis have shown important improvements in 
national immunization, characterized by an overall increase in the national 
and provincial coverage and a decrease in the number of children that did not 
receive any vaccine. Despite these improvements, some provinces have lower 
coverages than expected and it is necessary to understand the determinants of 
dropout in children to retain them and provide timely and full immunization.
Child; Immunization Coverage; Surveys
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Introduction
Children immunization is considered one of the most cost-effective strategies to reduce morbidity 
and mortality in children worldwide 1. Every year, up to three million lives are saved thanks to immu-
nization programs 1,2.
In 1974, the World Health Organization (WHO) established the Expanded Program on Immuni-
zation (EPI) to ensure that all children had access to routinely recommended vaccines 3. In response 
to challenges of the EPI worldwide, in 2006 the WHO and the United Nations Children’s Fund 
(UNICEF) developed the Global Immunization Vision and Strategy (GIVS) plan, a 10-year plan 
guiding countries to immunize as many people as possible against vaccine-preventable diseases, to 
introduce new vaccines and technologies and to provide other important interventions 4.
Immunization coverage is one of the main performance indicators used to measure the perfor-
mance of an immunization program, and it is defined as the proportion of people from a certain popu-
lation and time that received the last dose of vaccines to specific diseases. Knowing the immunization 
coverage is necessary to divide the number of vaccinated people for the total number of the popula-
tion eligible for vaccination 5,6. It was expected that in 2010 all the countries should have reached 
a national coverage of 90% and 80% in districts or administrative equivalent 4. After GIVS ended 
in 2010, in May 2012 the World Health Assembly (WHA) adopted the Global Vaccine Action Plan 
(GVAP) 2011-2020 for the decade aiming to prevent deaths by 2020 through more equitable access 
to existing vaccines for all communities, until 2013 2. This strategy was endorsed by 194 member 
states of the WHA with the following goal: all countries that reach more than 90% of national cover-
age for all vaccines in the country’s routine immunization schedule by 2020 will achieve a world free 
of poliomyelitis; meet vaccination coverage targets in every region, country, and community; exceed 
the millennium development goal four targets for reducing child mortality; meet global and regional 
elimination targets; develop and introduce new and improved vaccines and technologies 3. The fol-
lowing indicators are used to monitor the GVAP: national, district and DTP3 (diphtheria-tetanus-
pertussis) vaccination coverage, dropout (proportion of children who started but did not complete 
immunization series), the third dose of polio vaccine and the first dose of measles-containing vaccine 
(MCV1) coverage 2. 
The vaccination coverage in African countries has increased in the last decades, decreasing chil-
dren’s morbidity and mortality due to vaccines-preventable diseases. However, coverage rates, both 
national and vaccine-related, remain far from the recommended goal defined by the GVAP which still 
contributes to child morbidity and mortality across the African countries 7.
The US Centers for Disease Control and Prevention (CDC) and the WHO evaluated the global 
vaccine coverage by WHO regions to monitor the GVAP. They observed that African region presents 
the worst scenarios for the main indicators; for example, dropout is higher in this region (11%); DTP3 
has the lowest coverage (74%); among the 19.5 million children worldwide who did not receive DTP3 
doses during the first year of life, 11.8 million are divided into 10 countries, five of them African 
(Nigeria, Ethiopia, Democratic Republic of Congo, Angola, and South Africa) 8.
In Mozambique, the EPI was implemented in 1979 with the objective of reducing child mortal-
ity and morbidity through the provision of immunization services at all levels. Since then, several 
vaccines were introduced in the national immunization schedule supported by WHO, UNICEF, and 
Global Alliance for Vaccine Initiative (GAVI).
Between 1997 and 2015, five community surveys were carried out in the country to measure the 
main health indicators, including immunization coverage at national and provincial level 9,10,11,12,13. 
These surveys are powerful because mothers are interviewed in the community and asked for the 
children’s immunization cards which are copied to record the vaccination dates. Those mothers who 
did not present vaccination cards, verbal questions about vaccination and number of doses were 
recorded. The surveys are also important because they enable the assessment of equity in the provi-
sion of routine immunization services and to analyze how coverage behaves concerning the different 
health determinants such as sex, birth order, area of residence, mother’s education level, wealth quin-
tile, and others 14. Furthermore, it allows monitoring national and provincial coverage over the years, 
determining which vaccines are best performing and the country’s ability to comply with the GVAP. 
An analysis of this scale can be useful for policymakers to design strategies to improve the perfor-
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mance of national immunization program in a sustained manner, thus increasing vaccine-preventable 
diseases protection. Thus, the main objective of this manuscript is to review the available information 
related to vaccination in Mozambique since EPI implementation and to describe its characteristics, 
accomplishments in the past four decades, and the perspectives for the next years.
Methodology
A narrative review of the literature was carried out. The inclusion criteria for resources used was: (i) 
date of publication between January 1979 to December 2019; (ii) articles, reports, manuals, and offi-
cial websites published in English or Portuguese; and (iii) articles, reports, manuals, and official web-
sites with relevant information regarding immunization services/coverage and its determinants in 
Mozambique and Africa. Isolated (child; immunization; vaccine coverage; vaccine; Mozambique) and 
combined (immunization in Mozambique; vaccine coverage in Mozambique; child immunization in 
Mozambique; immunization coverage and Africa; EPI and Mozambique) keywords terms were used 
to selection, according to the most relevant content to the paper. 
We used two types of tools: (i) electronic databases namely Google Scholar, PubMed, and VHL 
and (ii) reports, websites and manuals from official sources. Two reviewers screened the titles and 
abstracts and selected original articles and other relevant sources.
Results and discussion
After removing the duplicate articles and those articles that did not meet the inclusion criteria, a total 
of 28 articles and 19 reports, 13 websites and two manuals have been selected for this analysis, totaling 
62 information sources (Supplementary Material. http://cadernos.ensp.fiocruz.br/static/arquivo/
suppl-csp-0383-20_5726.pdf).
Four main themes emerged from this revision: 
(1) The characteristics of EPI and vaccination policies in Mozambique had its information derived 
from research articles, publications on organizations websites, and official documents from national 
EPI, and WHO; 
(2) Operationalization of the immunization service, which information was derived from research 
articles and official documents from GAVI;
(3) Immunization coverage estimates by surveys, derived from national and international surveys and 
official documents from organizations working on immunization; and
(4) Monitoring of vaccine-preventable diseases, which information derived from research articles, 
publications on organization’s web pages and official documents.
Characteristics of EPI and immunization policies in Mozambique
In Mozambique, the EPI completed its 40th anniversary of implementation in 2019. EPI has commit-
ted itself to reduce child mortality and morbidity with immunization services at all levels, to achieve 
the long-term goal of reducing vaccine-preventable diseases 15,16. Before its establishment, from 1976 
to 1979, Mozambique carried out the first National Vaccination Campaign, where vaccines against 
smallpox, measles, tuberculosis, and tetanus (for women in childbearing age) were provided, which 
has shown remarkable health gains over the years, by the lives saved with the administration of such 
vaccines. Therefore, in 1980, immunization became part of routine child health services 16,17 by 
offering vaccines against tuberculosis (BCG), poliomyelitis (OPV), measles, and diphtheria-pertussis-
tetanus (DTP). This service was implemented in rural and urban areas and it was expanded to larger 
cities in 1983 17.
A few years later, cluster sample surveys have shown that the immunization coverage of children 
aged 12-23 months completely vaccinated in Maputo city, increased from an average of 38% to 84% 
between 1982 and 1986, respectively. The coverage of tetanus toxoid (TT2) for mothers also increased 
from 42% (1982) to 91% (1983) and it had a slight decrease to 87% three years later (1986). The other 
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four cities (Inhambane, Beira, Quelimane, and Tete) were also surveyed in 1985 and 1987 and the data 
presented an increasing average from 36% to 55% respectively, but on the other hand the coverage of 
TT2 decreased from 70% to 67% in the same period. Despite its significant accomplishments, thou-
sands of children were still getting sick and dying every year from vaccine-preventable diseases 18.
The 80-80 goals set in 2000 by the GAVI and the WHO, which objectives were reaching: (i) ≥ 80% 
of coverage of DTP3; (ii) in every district of more than 80% of developing countries by 2005, culmi-
nating with the creation of the Reaching Every District (RED) strategy in 2002 19. With the start of the 
GAVI support in the country in 2001, gradually, new vaccines (hepatitis B, followed by Haemophilus 
influenzae type B (Hib) in 2008, pneumococcal conjugate vaccine (PCV) in 2013, and rotavirus, inject-
ed polio, and measles second dose in 2015 were included in the national immunization schedule 18,20 
(Figure 1). In 2014, the country conducted a demo pilot for HPV vaccine for pre-teen girls in three 
districts, as a preparation for a national scale vaccination, but this vaccine is not yet included in the 
country schedule 18. In September 2019, the schedule was updated, with the addition of the measles-
rubella vaccine (Box 1). 
In 2008, strategies such as RED and National Health Week – where several immunization activi-
ties (vaccination in primary schools, health services to child and women in childbearing age, vaccine 
education, and mobilization) are carried out –, were implemented in order to increase coverage and 
reduce inequities related to the provision of vaccination services 20,21. Moreover, community health 
workers (CHW) have supported many health programs, including EPI by extending its services to 
the most vulnerable and disadvantaged population, thus achieving more satisfactory public health 
Figure 1
Mozambican Expanded Program on Immunization (EPI) most relevant events from 1979 to 2019.
GAVI: Global Alliance for Vaccine Initiative.
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Box 1
Current Mozambican immunization schedule, September 2019.
Vaccine Schedule
BCG (Bacillus Calmette-Guérin) At birth
Polio (oral polio vaccine) At birth, 2nd month, 3rd month, 4th month
DTP/HepB/Hib (diphtheria, tetanus texoid, pertussis, 
Haemophilus influenzae type B and hepatitis B)
2nd month, 3rd month, 4th month
Rotavirus 2nd month, 3rd month
PCV (pneumococal conjugate vaccine) 2nd month, 4th month, 9th month
IPV (injected polio vaccine) 4th month
Measles and rubella 9th month, 18th month
Vitamin A 6th month, 12th month, every six month until 59 
months
Deworming 12th month, every six months until 59 months
goals 22,23. The number of CHW in Mozambique has increased significantly from 170 (2010) to 3,051 
(2017), which may have reduced the geographical inequities as distances between health services and 
communities were shortened 24.
Operationalization of the immunization service: financing and stakeholders; cold chain 
and routine data flow
The Mozambican EPI financing support has been provided by several stakeholders namely: the 
Government of Mozambique, GAVI, Health Sector Common Fund (Prosaúde), the United States 
Agency for International Development (USAID), WHO, UNICEF, Bill & Melinda Gates Foundation 
(BMGF), Canadian International Development Agency (CIDA) 25 and other civil society organiza-
tions such as Foundation for Community Development (FDC) and Village reach 24. The GAVI and 
the Government of Mozambique (by the Mozambican Ministry of Health) are the major funders of 
EPI providing 64% (USD 234,743,835) and 23% (USD 20,638,423) of the budget respectively 16. Out 
of 64% of the budget provided by GAVI, 63% was for expenses related to new vaccine support (NVS) 
and the remaining 1% for ISS. Out of the 23% of the budget provided by the Government of Mozam-
bique, 18% were for general routine costs and 5% for co-financing of DTP and PCV vaccine 16. The 
2016 GAVI Full Country Evaluation reported that, the Government of Mozambique has annually 
provided funds for the procurement of traditional vaccines and its distribution by the national air-
line company 25. The Government of Mozambique expenditure on routine immunization made a 
satisfactory increment of 79% between 2011 (USD 3.4 million) and 2013 (USD 6.1 million), which 
clearly demonstrates the commitment of the government and its partners in improving the program.
According to the Comprehensive Multi-Year Plan, the total EPI expenditure in Mozambique for 
the period of 2014-2019 was estimated at USD 351.3 million (excluding shared costs of USD 6.9 mil-
lion), an average of USD 68.9 million annually, and the routine immunization (national health weeks 
and outreach services excluded) uses 88% of the budget 16.
The GAVI has been in the funding frontline of the immunization services of many low and mid-
dle-income countries 26, including Mozambique, playing an important role in the reduction of deaths 
by preventable diseases in young children. 
Countries can apply for four types of support to help them address coverage inequity: (i) vaccine 
introduction and campaigns; (ii) health system strengthening; (iii) cold chain equipment, and (iv) 
technical assistance 27.
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The GAVI support in Mozambique began in 2001, as it has been in the list of eligible coun-
tries from which support is provided through request based on their national vision, planning, and 
financial cycles. The support has started by providing ISS and shortly thereafter by supporting the 
introduction of vaccines such as tetra DTP-HepB (2001-2007), pentavalent vaccine (2009-2019), PCV 
(2013-2019), HPV demonstration (2014), measles second dose (2015-2017), IPV (2015-2019), and 
rotavirus (2015-2019) 25.
According to the 2016 GAVI Full Country Evaluation, during 2013, 2014 and 2015, the contri-
bution of GAVI to the EPI total budget was 31%, 71%, and 75% respectively, and the largest funding 
was observed in 2015, with the first disbursement of the health system strengthening support and 
the introduction of new vaccines namely rotavirus, IPV, and measles second dose 25. For the period, 
from 2000 to 2019, the GAVI has made a disbursement of USD 259,723,474 for all types of support. 
Particularly, GAVI has committed to support with about USD 5,128,062 the cold chain equipment 
optimization platform to from 2001-2023, more than 11% of the approved budget 28. According to 
the EPI inventory carried out in 2003, 88% (1,449/1,638) of the total refrigerators were functional, 
but a national review from 2006 showed that significant investment to update the cold chain equip-
ment was necessary. Vaccine poor conditions, temperatures not being recorded as specified, inad-
equate stock records were some of the weaknesses at the health facility and district level and they 
had to be improved 15. Data from the Mozambican Ministry of Health reports that, in an assessment 
carried out in 2012, the cold chain did not have enough capacity to introduce new vaccines, such 
as rotavirus and measles second dose to the system; and out of the 11 provinces, only eight could 
accommodate the vaccines planned to be introduced 29. A national cold chain plan for 2014-2018 
referred to the need for expanding the cold chain to accommodate the new vaccines to the EPI. 
The plan also contemplates several reforms to the cold chain system, since the creation of regional 
vaccine depots (to Center and North region), replacement of old/worn-out equipment, acquisition 
of temperature monitors to all levels of the system and also training of cold chain maintenance 
technicians at provincial and district level 29. The introduction of new vaccines in the immunization 
schedule in 2015 demonstrates the adoption of the plan recommendations with the intervention of 
different stakeholders. 
Since GAVI support started in the country, the vaccine coverage has increased over time as sur-
veys have demonstrated. Although this support plays an important role, the waiting time associated 
with  financing cycles, from the moment of the support request until its implementation, may lead to 
changes in EPI priorities and also influence the outcome of immunization coverage 26.
The support provided by GAVI can be masked by country-specific issues that do not help to 
meet expected coverage goals. Until 2018, the nurse/midwifery staff ratio in the country was 0.7 per 
1,000 habitants, a low ratio when compared to Zimbabwe (1.9), and Zambia (1.3) 30. These are the 
main health personnel in the front line providing women and child health care in low- and middle-
income countries, which may suggest a weakness in the availability of human resources to support 
the provision of vaccination services. Mozambique is a country located on the cost of the Indian 
Ocean, vulnerable to climatic effects and natural disasters (rains, cyclones, droughts), and these may 
substantially contribute to the destruction of access roads, people migration, and consequent inter-
ruption of healthcare services, including immunization. According to the Southern African Develop-
ment Community (SADC) Statistical Yearbook from 2015, the density of the Mozambican population 
was estimated at 32 people per square kilometer (km2), which is lower than Zimbabwe (36 people/
km2) and Tanzania (55 people/km2), showing a greater dispersion of communities and the need of 
extra effort to reach people, mostly in restricted areas. Although immunization services are available 
in 90% of the health units, the National Inventory to the health facilities shows that the availability 
of vaccines for children was found in only 65% of them. The same inventory has shown that all basic 
vaccines were under stock rupture in the last three months before the survey, with pneumococcal and 
poliovirus vaccine being the most ruptured 31.
To what concerns the provision of immunization service, this is part of the primary health ser-
vices and it is provided by health facilities and outreach services. The collection of routine data starts 
at this point and it is where the estimates of administrative coverage from the Mozambican Ministry 
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of Health is originated, which are collected firstly from health facilities, districts and then to central 
level 32. After a child is vaccinated in the health facility or by outreach service, data of all received 
vaccines are recorded into specific tally sheets (A01), and for the tetanus toxoid vaccine a different 
one (A02) is also filled out. These data are collected monthly in a health facility and outreach tally 
sheet (A03) and then all data from several facilities are aggregated at the district level in a specific 
district tally sheet (A04). Then, the district sends the data monthly to the provincial level, and after 
entering it in the database, these are sent to national level quarterly 33.
In 2005, a study conducted at a district level aimed to evaluate data quality and record-keeping 
practices from routine data was published. It showed differences for all types of vaccine between 
health facilities with the tally sheets reports, higher values to health facilities when compared to the 
original tally sheets. The study was conducted in seven health facilities of which only one reported 
consistent data for all vaccines excepting BCG, and another facility reported underestimated data for 
all vaccines when compared to the tally sheets. Comparing health facilities and tally sheets, an average 
increase of 7% for all vaccines were reported. Also, some differences related to the number of vaccines 
were found between health facilities and district reports 33.
Furthermore, single monthly analyzes of health facilities showed some data reports on immunized 
children in months that not even one children record in the immunization tally sheets was made, rea-
sons reported for these inconsistencies were threats regarding salary cuts in case of low performance 
of health works. On the other hand, immunization services were performed but no reports to the 
district level were made 33. Although supervision visits in health facilities occur months prior to the 
study, these visits were primarily focused on data-quality assessment for outpatients and not directed 
to data consistency between facilities reports and tally sheet records. A data quality audit conducted 
in 2002 and a data quality self-assessment conducted in several districts by provinces between 2010-
2012 showed that there is a continued poor data management of immunization routine data. Addi-
tionally, over and underreporting remains a problem in all levels 16,29. Data accuracy, completeness, 
timeless report, inconsistency between different levels, poor filling of the vaccination registration are 
some of the challenges in the immunization services and they exist for many years.
Immunization coverage estimates by surveys  
• National, provincial and vaccine coverage 
National Demographic Health Surveys (DHS) show that immunization coverage is increasing slowly. 
In 1997, the national estimate of immunization coverage was 47%, with a great increase to 63% in 
2003. Then, in 2008 the coverage dropped to 60%, and it increased to 64% and 66% in 2011 and 2015 
respectively 9,10,11,12,13 (Figure 2). However, the absence of surveys between 2016 and 2019 does not 
allow data analysis for the last four years. 
The Mozambican’s immunization coverage of children aged 12-23 months in the last survey 
is higher when compared to Angola’s (DHS 2015-2016) and South Africa’s (DHS 2016) with 31% 
and 61% respectively 34,35. On the other hand, Zambia (DHS 2018) and Tanzania (DHS 2015-2016) 
reported coverage of 75%, also Zimbabwe (DHS 2015) and Malawi (DHS 2015-2016) reported both a 
coverage of 76% when compared to Mozambique 36,37.
Regarding the provincial level, Maputo city and its province have been constantly reporting high-
er immunization coverage in all surveys when compared to other provinces. Therefore, Zambézia, 
Nampula, and Tete provinces presented constantly lower coverages in all surveys, but Nampula and 
Zambézia are the most densely provinces 9,10,11,12,13.
While most provinces, maintain a stable position regarding both increase or decrease of coverage, 
Cabo Delgado coverage oscillates over time (Table 1) 9,10,11,12,13. Among African countries, Zimbabwe 
reported coverage of 91% at the provincial level, the highest value when compared to Mozambique, 
Angola, Zambia, and South Africa. These value possibly shows a geographical inequity in the provi-
sion of immunization services 34,35,37,38.
The GVAP on the goal set to 2015-2020, determined (a) polio eradication after 2014, (b) by 2015 a 
90% of children protected with DTP3 and Mozambique reached in 2015 the goal of DTP3. Regarding 
poliovirus, the country was able to interrupt the circulation of wild poliovirus in 2016 39, although 
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Figure 2
Trends of national and vaccine coverage between 1997 and 2015 surveys. Mozambique.
DTP3: diphtheria pertussis-tetanus (DTP3); PCV10: 10-valent pneumococcal conjugate vaccine.
Table 1
Immunization coverage by Mozambican provinces from 1997 to 2015.
Province Surveys
1997 2003 2008 2011 2015
Cabo Delgado 25.4 57.9 70.5 58.5 86.2
Niassa 48.2 46.6 56.4 77.2 78.0
Nampula 34.4 53.9 51.4 66.3 52.1
Zambézia 23.2 44.7 47.6 47.3 49.9
Tete 48.0 55.0 34.2 58.0 53.1
Manica 46.5 61.6 58.3 64.6 65.8
Sofala 49.6 63.9 72.3 78.4 69.1
Inhambane 71.7 90.6 79.8 64.7 81.0
Gaza 63.0 82.3 73.9 76.3 84.8
Maputo province 61.9 92.5 81.9 87.9 82.8
Maputo city 82.0 91.3 81.9 76.7 87.1
polio’s outbreaks derived to polio vaccine (type one and type two) are still reported through the acute 
flaccid paralysis (AFP) surveillance.
The surveys evaluated information regarding specific vaccine among children aged between 12 
and 23 months, as this group is considered to have had all essential vaccines (BCG, DTP3, Polio 3, and 
Measles). Among all essential vaccines BCG has shown the highest coverage and a significant increase 
from 1997 to 2015 with 78% and 93% respectively. The highest coverage in this vaccine can be justi-
fied as it is administered in newborns at birth in the health facility. Polio 3 (55% and 87%) and DTP3 
(58% and 82%) vaccines present high and almost similar coverages as well, which can be justified by 
their being administered at the same time. The measles vaccine shows a great increase from 1997 
(54.7%) to 2015 (82.7%). The PCV10 vaccine was introduced in 2013 and the IMASIDA’s survey could 
estimate a lower coverage of 75.7%, for the first time in children aged 12 to 23 months (Figure 2). 
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Annual estimates from WHO/UNICEF and official estimates from the Mozambican Ministry of 
Health enables the determination of specific vaccine coverage from 2016 to 2017 and their cover-
age reports presents considerable differences. Estimates from the Ministry of Health are very high 
compared to WHO/UNICEF estimates, and the major difference can be verified in data from 2017, 
in which most vaccines reached the coverage of 99% reported by the Ministry of Health compared to 
the range between 80% and 96% reported by WHO/UNICEF.
Mozambique did not achieve the goal of 90% national coverage in 18 years from the first survey 
until the last (1997-2015), the national highest coverage reported so far is 66% from 2015 survey 13 as 
recommended by GIVS 4. Regarding provincial level, the last survey published in 2015, showed that 
only Southern provinces (Maputo province, Maputo city, Inhambane, and Gaza) and the Northern 
province of Cabo Delgado succeed to reach the 80% coverage goal 9,10,11,12,13. This shows inequities 
in the provision of health services in Mozambique and considerable geographical variation. Comple-
mentary researches are necessary to better understand this phenomenon.
• Immunization coverage in children under 12 months
The immunization schedule indicates that children aged under 12 months must have received all basic 
vaccines (BCG, Polio 3, DTP3, and measles) however, surveys data show lower coverage in almost two 
decades, from 44.3% in 1997 to 57% in 2015 9,10,11,12,13. Under the SADC countries, the Mozambican 
immunization coverage in this group is lower when compared to South Africa (58%), Lesotho (60%), 
Namibia (63%), Tanzania (68%), Zimbabwe (69%), Malawi (70%), and Eswatini (74%) in their last DHS, 
but higher when compared to Angola (28%), Democratic Republic of Congo (41%), and Madagascar 
(55%) 34,36,38,40,41,42,43. This data provide two important messages: (i) the optimal coverage is still 
a challenge in Mozambique and the country is far of reach the global indicators and (ii) EPI must 
improve the services and access to vaccination at all levels and also focus in younger infants.
• Vaccine dropout rate
Vaccine dropout is the proportion of children who started vaccination but did not complete it, 
between the first and the last dose, mainly measured by estimating the coverage percentage of DTP1 
minus DTP3/DPT1 coverage*100 44 and this indicator allows the evaluation of EPI performance. 
The rate of vaccination dropout in African countries is 11%, which is above the GVAP target (≤ 10%) 
when compared to the Western Pacific region with 0.4% estimated in 2016 with DTP3 vaccine 8. In 
Mozambique, the rate of vaccine dropout of DTP3 and Polio 3 vaccines is still high. However, between 
1997 and 2015 the dropout of DTP3 decreased from 21% to 8.4%, and Polio 3 also reduced from 28% 
to 18.5% respectively. Angola’s DHS (2015-2106) has shown that the dropout rate for the same vac-
cines is 29% and 26%, which is beyond the GVAP goal. Whereas in Zimbabwe 2015 DHS, the dropout 
rate for DTP3 and Polio 3 was 7% and 8%, respectively. An analysis conducted in 15 West African 
countries from the Economic Community of West African States (ECOWAS), using the WHO and 
UNICEF estimates of national immunization coverage from 2000 to 2017, showed that the average 
dropout reduced from 16.4% to 7.4% in 17 years, showing stability of the GVAP target for nine years 
(since 2008). The same study has shown that some characteristics such as residing in urban areas, 
people living in regions with the highest coverage, the wealthiest quintile, mothers with a secondary 
education level or higher, are relevant to reduce dropouts values 45.
In Ghana (Techiman), a study where the dropout rate was determined by using the BCG (as the 
first vaccine in their EPI schedule) and Measles (as the last vaccine), the dropout of BCG-Measles was 
5.6% 44. Also, children of married mother, profess to the Christian religion were presented as less 
likely to dropout. Nevertheless, male children and not presenting an immunization card were related 
to the abandonment of the immunization schedule in the same study 44.
The decrease of Mozambique dropout rate over the years is a relevant demonstration that signifi-
cant progress of EPI services is occurring, however, reasons to vaccine dropout are poorly understood 
and measures need to be taken to understand why polio vaccine has a higher dropout rate 9,10,11,12,13.
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• Determinants of immunization coverage 
Immunization coverage in Mozambique has been increasing slowly over the past decades and sev-
eral determinants may be associated with lower national and provincial coverage. Surveys data have 
shown that: (i) mothers with poor education level, (i) lowest wealth quintile, and (iii) residing in urban 
areas, are the main determinants to incomplete immunization status 9,10,11,12,13. Regarding the area 
of residence, the urban coverage has shown to be higher when compared to the rural coverage in all 
surveys. In 1997 the difference between urban and rural coverage was 85% and 36.4% respectively, 
later in 2015 the significant difference between urban (77.9%) and rural (67.1%) was still observed. 
However, the vaccination coverage in rural areas tends to increase compared to the urban which is 
linear in different surveys, which can be explained by the high growth rate of the urban population in 
the country with 3.3% per year 46.
In 1997 the immunization coverage was 89.7% for mothers who completed secondary/higher 
education level when compared to mothers who did not attend to school with 30.6%. In the last 
survey of 2015 this inequity is still verified in these two groups, with 84.7% to children from moth-
ers with higher education levels and 52.5% for those whose mothers did not attend school. Wealth 
quintile was not measured in 1997, however in all other surveys a higher immunization coverage is 
presented for children from households with the highest quintile (Table 2). In Africa, many deter-
minants have been associated with incomplete immunization status: in Ghana being a divorced 
mother and having part-time work were positively associated with incomplete immunization 47. In 
Cameron, a survey conducted in the West region showed that mothers’ lower use of antenatal visits, 
being ≥ 3 born child, younger mothers, parental poor exposure to information about immunization 
was significantly associated with incomplete immunization 48. A secondary analysis from Senegal 
DHS has shown that mothers who could show immunization cards, complete secondary/higher 
education level, attend to at least four antenatal visits, and childbirth in a health unit were associated 
with full immunization status 49. In Ethiopia, being a father with secondary school, having a higher 
family income, an average walking time of one hour to vaccination place, discussing immunization 
with health workers and mothers with knowledge of immunization was also associated with com-
plete immunization status 50. Studies to identify determinants of immunization in Mozambique are 
scarce, the few existing have been carried out in the Southern provinces of the country. These indi-
cate that the poor access to vaccination places, mother’s low education level, childbirth at home or 
outside the health unit, and area of residence were the reasons for incomplete vaccination 51,52. Thus, 
the epidemiology of children with incomplete vaccination and its determinants in African countries 
can be related to household characteristics, caregiver’s attitudes and knowledge, communication and 
information, and immunization services performance. A more in-depth analysis, covering all regions 
of the country, is necessary to support the determination of the main factors that lead to the failure 
in reaching the established goals.
Table 2
Immunization coverage according to sociodemographic aspects (education level, wealth quintile, and area of residence). Mozambique,  
from 1997 to 2015.





Lowest Second Medium Fourth Highest Rural Urban
1997 30.6 54.3 89.7 NA NA NA NA NA 36.4 85.0
2003 48.6 73.6 97.6 45.2 53.6 60.9 78.7 50.3 56.0 80.5
2008 53.1 61.7 78.5 47.2 50.6 61.9 70.7 78.8 54.9 74.3
2011 58.1 65.2 75.4 53.8 57.3 66.3 73.5 75.5 60.0 75.0
2015 52.5 67.2 84.7 52.7 54.5 67.1 81.0 85.1 67.1 77.9
NA: not applied.
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Monitoring of the vaccine-preventable diseases
The Mozambique Integrated Disease Surveillance and Response Handbook defines diseases as being 
required to report: polio (AFP), measles, rubella, neonatal tetanus, cholera, hemorrhagic fevers (Mar-
burg, Ebola, rift valley, chikungunya, dengue) rotavirus, and pandemic influenza. 
• Polio
One of the decade goals is to achieve a world free of poliomyelitis 2. In Mozambique, the last case of 
poliomyelitis caused by wild virus strain was reported in 1993. In 1997, the country established sur-
veillance by laboratory diagnosis of samples with suspected cases of AFP. In 2006 the WHO issued a 
wild virus free country certification and the country has maintained this certification so far. Between 
2011 and 2018 the country recorded a poliomyelitis event and outbreak in Zambézia province both 
derived from the vaccine strain. In 2018, two outbreaks of circulating vaccine-derived poliovirus 
type 2 virus were identified in Zambézia province in Molumbo district 53. As strategy to block the 
circulation of poliovirus in Molumbo, in 2019 the Mozambican Ministry of Health in collaboration 
with several partners started mOPV2 massive immunization campaign. It is necessary to understand 
the causes of unimmunized children in outbreak areas to design strategies to reach them.
• Measles and rubella
The Mozambican National Institute of Health (INS) implemented surveillance for measles and 
rubella in 2006 following WHO recommendations 54. The suspected cases are notified by the Weekly 
Epidemiological Bulletin (WEB) and the case investigation are carried out with laboratory serology 
confirmation 55. 
Out of the 53,251 reported measles cases in Mozambique between 2003 and 2010 56, more than 
25,000 were from 2003 alone, registered as one of the largest post-independence measles epidem-
ics 55. Between 2006 and 2014, the proportion of children with confirmed rubella was 4.5% for chil-
dren under 1 year and 13.1% for those aged between 1and 4 years 54. National campaigns were con-
ducted throughout the country, in 2005 (from 9 months to 14 years old children), 2008 (from 9 to 59 
months old), 2011 (from 6 to 59 months old) 54 and more recently in 2018 a combined measles and 
rubella campaign was conducted aiming to benefit more than 12 million children aged 6 months to 
14 years 57. However, cases continue to occur with 2,599 suspected cases and 29 confirmed results 
for 2018 (source: unpublished data of the INS). For many years, a single dose of measles vaccine 
was administered in children aged 9 months 58 but since 2015 a second dose is administered at 18 
months old and more recently a combined measles-rubella (MR) vaccine was updated in the sched-
ule. All these initiatives are expected to support the struggle against measles and rubella cases that 
the country has been reporting, especially in the areas that these diseases are recurrent.
• Meningitis
The pneumococcal conjugate 10-valent vaccine (PCV10) was introduced in the country in April 2013, 
using a 3-dose schedule without booster. The effect of this vaccine on the burden of pneumococcal 
meningitis was accessed by surveillance in children less than 5 years old in the three largest hospitals 
of Mozambique 59. The results showed a decrease in the cases of pneumococcal meningitis from 
33.6% in 2013 to 1.9% in 2015. A change in the pneumococcal serotype prevalence was observed after 
the introduction of PCV10 in Mozambique with the predominance of serotypes not covered by the 
vaccine 59. Thus, the National Expert Committee on Immunization in Mozambique (COPI) recom-
mended a replacement from the PCV10 to PCV13 to cover more serotypes and a non-stop surveil-
lance to monitor changes in the prevalence of the serotypes 24.
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• Rotavirus
A surveillance system based on sentinel sites was implemented in 2014 by the INS. Rotarix vaccine 
was introduced in the EPI in September 2015. Data from the period before vaccine introduction 
showed that rotavirus prevalence was higher than 40% 60 and that rotavirus was the principal agent 
attributed to diarrhea in children aged under five years 61. As a result of the vaccine introduction, the 
frequency reduced to 13.5% in the second year post-vaccine 62. 
A recent analysis showed that due to several actions implemented in the country including 
vaccination against rotavirus, a significant reduction in the burden of diarrhea in Mozambique is 
observed 21. 
EPI next steps and perspectives
For the next years (2021-2025), Mozambique hopes to continue to receive the support of GAVI, for 
which has submitted a proposal focused on interventions in the provinces with the worst immuniza-
tion performance. 
Recognizing the main gaps in the system, three main objectives can be defined: (a) Ensure the 
vaccines availability in 98% at all levels, to achieve coverage. This includes the improvement of the 
cold chain and data management; (b) Improving the leadership and management based on knowledge, 
skills, evidence, and fully integrated coordination. This will include operational research for deci-
sion making on quality service delivery; (c) Provide good quality immunization, engagement with 
the community and effective communication to reduce the incidence of vaccine-preventable disease.
Study limitations
The lack of surveys in the period between 2016 and 2019, does not allow us to continually evaluate 
national and provincial coverage and vaccination trends in recent years. However, there are official 
data in this period. One of the big challenges is related to the differences among official reports and 
WHO/UNICEF estimates which can be explained by several reasons, one of them, the methodology 
of data collection. WHO/UNICEF’s are based on community surveys, official data or/and other data 
available in the country using statistical and mathematics estimates. Whereas the official data are 
derived from Mozambique’s administrative data or other sources reported by the country authorities. 
Although low data quality, registration book incompleteness, timelineless, issues with numerator and 
denominator which drives for covers up to 100% are implicated in official data, that is why in this 
article is focused on surveys and WHO/UNICEF data.
Another significant limitation is the methodology used for a narrative review which has a differ-
ent approach for the selection of the used literature as it is done by convenience considering what is 
available regarding the topic when compared to systematic reviews.
There is no information on other factors that may be related to low coverage in Mozambique, 
other countries already carry out a secondary analysis of surveys to better understand the weaknesses 
and successes of their immunization programs. Robust analyzes must be carried out in Mozambique 
to understand which other determinants may be related to incomplete immunization status and fig-
ure how they can be improved.
Final remarks and conclusions
As far as we know, this is the first narrative review containing relevant information about the immu-
nization program in Mozambique in post-independence. Through this process, 28 articles have been 
selected, from which one was related to financing; four were related to the EPI worldwide and the 
goals set; seven were related to coverage immunization determinants in African countries; 10 related 
to immunization in Mozambique, and six related to monitoring vaccine-preventable disease.
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The literature used during the analysis have shown a gap related to the identification of the main 
determinants to low immunization coverage in Mozambique, either nationally or locally. We found 
no information regarding how the lack of human resources, stock rupture of vaccines, natural disas-
ters in the country have affected the performance of the EPI over time.
Forty years of EPI in Mozambique have shown significant improvements in the national immu-
nization, characterized by the introduction of strategic vaccines, an overall increase in the national 
and provincial coverage, a decrease in the number of children that did not receive any of the basic 
vaccines, implementation of strategies to increase the immunization coverage and the establishment 
of monitoring system of the VPD as an important tool to detected outbreaks and to respond appro-
priately to these events.
However, national coverage remains below the WHO recommendation of 90%. There are prov-
inces (Zambézia, Nampula, and Tete) that have been continuously reporting low immunization cover-
age over the years and some, as Cabo Delgado with oscillating coverage.
It is necessary to understand the determinants of low coverage and also the factors related to 
dropouts of Polio vaccine in order to retain these cases, providing timely and full immunization. The 
constant outbreaks of cholera, polio, and measles that have been reported in the provinces previously 
mentioned is an equally relevant aspect. The aspects raised above, suggest the need for operational 
research, thus creating evidence that can guide decision-makers, also improving the immunization 
indicators in Mozambique.
One of the major findings of this manuscript is the fact that less than 25% of the budget of total 
immunization services is provided by the government. The other 75% of the budget is funded by 
external support such as GAVI, which have been reaching its goal, considering that coverage numbers 
are notably improving. However, some bottlenecks such as availability of human resources, vaccine 
stock rupture, geographical dispersion of some communities, may affect the effectiveness of the 
immunization service.
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Resumo
Em Moçambique, o Programa Alargado de Va-
cinação (PAV) foi implementado em 1979 com o 
compromisso de reduzir a morbimortalidade na 
população infantil através dos serviços de imu-
nização. O presente estudo tem como objetivo 
descrever as características do PAV e revisar as 
informações disponíveis relacionadas aos servi-
ços de imunização em Moçambique, os avanços e 
perspectivas. Foi realizada uma revisão narrativa 
da literatura, e as bases de dados acessadas foram 
BVS, Google Scholar e PubMed, entre 1979 e 2019, 
usando descritores relacionados ao tema. A revisão 
acessou um total de 28 artigos científicos, além de 
outras fontes relevantes. A cobertura nacional de 
vacinação em Moçambique entre 1997 (47%) e 
2015 (66%) aumentou 19 pontos percentuais, e a 
cobertura de vacinação em crianças abaixo de 12 
meses de idade aumentou de 44,3% (1997) para 
57% (2015). De acordo com os dados de 2015, das 
11 províncias, apenas as do Sul e a de Cabo Del-
gado atingiram a meta de cobertura recomenda-
da de 80%. As províncias de Zambézia, Nampula 
e Tete mostraram baixas coberturas ao longo dos 
anos, enquanto Cabo Delgado mostrou oscilação 
na cobertura. As vacinas BCG, DPT3, Polio 3 e 
sarampo atingiram a meta de cobertura de 80% 
entre 1997 e 2015. Nossa análise mostrou avanços 
importantes na vacinação nacional, caracteriza-
dos por um aumento geral nas coberturas nacional 
e provinciais e uma queda no número de crianças 
que não receberam nenhuma vacina. Apesar desses 
avanços, algumas províncias tiveram coberturas 
aquém das metas, o que reforça a necessidade de 
entender os determinantes do abandono da imu-
nização nas crianças, para retê-las e assegurar a 
imunização oportuna e completa. 
Criança; Cobertura Vacinal; Inquéritos
Resumen
En Mozambique, el Programa de Inmunización 
Expandido (EPI por sus siglas en inglés) fue im-
plementado en 1979, con el compromiso de reducir 
la mortalidad infantil y la morbilidad a través de 
la provisión de servicios de inmunización. El obje-
tivo del presente estudio es describir las caracterís-
ticas del EPI y revisar la información disponible, 
relacionada con el servicio de inmunización en 
Mozambique, así como sus logros y perspectivas. 
Se llevó a cabo una revisión narrativa de la lite-
ratura y se accedió a las siguientes bases de datos 
electrónicas: BVS, Google Scholar y PubMed para 
el período de 1979 a 2019, usando descriptores re-
lacionados con el tema. Se tuvo acceso a un total 
de 28 artículos y otras fuentes relevantes para la 
revisión. La cobertura nacional de inmunización 
en Mozambique de 1997 (47%) a 2015 (66%) me-
joró 19 puntos porcentuales y la cobertura de in-
munización de los niños con menos de 12 meses se 
incrementó de un 44,3% (1997) a un 57% (2015). 
La encuesta de 2015 mostró que, de las 11 provin-
cias, solamente la provincia del sur y la provincia 
de Cabo Delgado podrían alcanzar el 80% de la 
meta recomendada a nivel provincial. Las pro-
vincias de Zambézia, Nampula, y Tete han estado 
informando de baja cobertura a largo de estos años 
y Cabo Delgado tiene oscilaciones en la cobertura. 
BCG, DPT3, Polio 3 y sarampión han alcanzado 
un 80% de la meta de la cobertura de 1997-2015. 
Nuestro análisis ha mostrado importantes mejoras 
en la inmunización nacional, caracterizada por 
un aumento en general en la cobertura nacional 
y provincial, así como un decremento en el núme-
ro de niños que no recibieron ninguna vacuna. A 
pesar de estas mejoras, algunas provincias tienen 
coberturas más bajas que las esperadas y existe 
una necesidad para entender los determinantes del 
abandono en niños para retenerlos y proporcio-
narles a tiempo una completa inmunización. 
Niño; Cobertura de Vacunación; Encuestas 
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